Lesinurad: A Review in Hyperuricaemia of Gout.

about

Recent advances on uric acid transporters.Novel uricosurics.Physiology of Hyperuricemia and Urate-Lowering Treatments.

P2860

Q47131336-21361A93-1290-45D7-9C96-CF27AFD6CEE9 Q49616067-0BE3A422-0FB8-407E-B899-797A5FB2A0C9 Q55163806-9C17F1C1-A7A1-477C-8374-4F26237189C6

P2860

Lesinurad: A Review in Hyperuricaemia of Gout.

Item

http://www.wikidata.org/entity/Q39251437

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Lesinurad: A Review in Hyperuricaemia of Gout.

@en

Lesinurad: A Review in Hyperuricaemia of Gout.

@nl

type

Item

label

Lesinurad: A Review in Hyperuricaemia of Gout.

@en

Lesinurad: A Review in Hyperuricaemia of Gout.

@nl

prefLabel

Lesinurad: A Review in Hyperuricaemia of Gout.

@en

Lesinurad: A Review in Hyperuricaemia of Gout.

@nl

P1476

Lesinurad: A Review in Hyperuricaemia of Gout.

@en

P2093

Emma D Deeks

http://www.w3.org/2001/XMLSchema#string

P2860

2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol

Treatment of hyperuricemia in gout: current therapeutic options, latest developments and clinical implications

Gout.

2016 updated EULAR evidence-based recommendations for the management of gout.

A review of uric acid, crystal deposition disease, and gout.

Management of Acute and Recurrent Gout: A Clinical Practice Guideline From the American College of Physicians.

Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective Analysis.

Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney.

Supratherapeutic dose evaluation and effect of lesinurad on cardiac repolarization: a thorough QT/QTc study

P2888

s40266-017-0461-y

P304

401-410

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40266-017-0461-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28425024

http://www.w3.org/2001/XMLSchema#string

Lesinurad: A Review in Hyperuricaemia of Gout.

about

P2860

P2860

Lesinurad: A Review in Hyperuricaemia of Gout.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698